Literature DB >> 12325031

Evidence of a founder effect for the RETGC1 (GUCY2D) 2943DelG mutation in Leber congenital amaurosis pedigrees of Finnish origin.

Sylvain Hanein1, Isabelle Perrault, Päivi Olsen, Tuija Lopponen, Marja Hietala, Sylvie Gerber, Marc Jeanpierre, Fabienne Barbet, Dominique Ducroq, Sélim Hakiki, Arnold Munnich, Jean-Michel Rozet, Josseline Kaplan.   

Abstract

Leber congenital amaurosis (LCA) is the earliest and most severe form of all inherited retinal dystrophies. It is a genetically heterogeneous condition as six disease-causing genes have been hitherto identified. Among them, RETGC1 (GUCY2D), is more frequently implicated in our series of LCA patients. Interestingly, 70 % of the families with RETGC1 mutations are originating from Mediterranean countries, the remaining families (30%) being originating from various countries across the world. Here, we report, the identification of the same homozygous RETGC1 nonsense mutation in three unrelated and non-consanguineous LCA families of Finnish origin, suggesting a founder effect. Interestingly, no linkage desequilibrium was found using polymorphic markers flanking the RETGC1 gene, supporting the view that the mutation is very ancient. Haplotype studies and Bayesian calculation point the founder mutation to 150 generations (95% credible interval 80-240 generations), i.e., 3000 years ago. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12325031     DOI: 10.1002/humu.9067

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

1.  Comprehensive genotyping reveals RPE65 as the most frequently mutated gene in Leber congenital amaurosis in Denmark.

Authors:  Galuh D N Astuti; Mette Bertelsen; Markus N Preising; Muhammad Ajmal; Birgit Lorenz; Sultana M H Faradz; Raheel Qamar; Rob W J Collin; Thomas Rosenberg; Frans P M Cremers
Journal:  Eur J Hum Genet       Date:  2015-12-02       Impact factor: 4.246

2.  [Genetic and clinical heterogeneity in LCA patients. The end of uniformity].

Authors:  M N Preising; K Paunescu; C Friedburg; B Lorenz
Journal:  Ophthalmologe       Date:  2007-06       Impact factor: 1.059

3.  Novel GUCY2D mutation causes phenotypic variability of Leber congenital amaurosis in a large kindred.

Authors:  Libe Gradstein; Jenny Zolotushko; Yuri V Sergeev; Itay Lavy; Ginat Narkis; Yonatan Perez; Sarah Guigui; Dror Sharon; Eyal Banin; Eyal Walter; Tova Lifshitz; Ohad S Birk
Journal:  BMC Med Genet       Date:  2016-07-30       Impact factor: 2.103

4.  Genetic spectrum of retinal dystrophies in Tunisia.

Authors:  Imen Habibi; Yosra Falfoul; Ahmed Turki; Asma Hassairi; Khaled El Matri; Ahmed Chebil; Daniel F Schorderet; Leila El Matri
Journal:  Sci Rep       Date:  2020-07-08       Impact factor: 4.379

5.  Clinical and Genetic Analysis of RDH12-Associated Retinopathy in 27 Chinese Families: A Hypomorphic Allele Leads to Cone-Rod Dystrophy.

Authors:  Junwen Wang; Yingwei Wang; Shiqiang Li; Xueshan Xiao; Zhen Yi; Yi Jiang; Xueqing Li; Xiaoyun Jia; Panfeng Wang; Chenjin Jin; Wenmin Sun; Qingjiong Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-08-02       Impact factor: 4.925

6.  Union makes strength: a worldwide collaborative genetic and clinical study to provide a comprehensive survey of RD3 mutations and delineate the associated phenotype.

Authors:  Isabelle Perrault; Alejandro Estrada-Cuzcano; Irma Lopez; Susanne Kohl; Shiqiang Li; Francesco Testa; Renate Zekveld-Vroon; Xia Wang; Esther Pomares; Jean Andorf; Nisrine Aboussair; Sandro Banfi; Nathalie Delphin; Anneke I den Hollander; Catherine Edelson; Ralph Florijn; Marc Jean-Pierre; Corinne Leowski; Andre Megarbane; Cristina Villanueva; Blanca Flores; Arnold Munnich; Huanan Ren; Ditta Zobor; Arthur Bergen; Rui Chen; Frans P M Cremers; Roser Gonzalez-Duarte; Robert K Koenekoop; Francesca Simonelli; Edwin Stone; Bernd Wissinger; Qingjiong Zhang; Josseline Kaplan; Jean-Michel Rozet
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.